Article
Effect of genetic polymorphism of OATP-C (SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors.
Drug metabolism and pharmacokinetics - 1 Oct 2004
Tachibana-Iimori Rieko, Tabara Yasuharu, Kusuhara Hiroyuki, Kohara Katsuhiko, Kawamoto Ryuichi, Nakura Jun, Tokunaga Katsushi, Kondo Ikuko, Sugiyama Yuichi, Miki Tetsuro
Abstract excerpt
The effect of genetic polymorphism of human organic anion transporting polypeptide C (OATP-C) on the lipid-lowering response to 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors was assessed. A retrospective study was conducted on 66 patients who underwent treatment of hyperlipidemia...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
